Market Access & HEOR
Whether you have critical decisions to make about trial design, an imminent asset launch, or an established brand approaching LoE, Ipsos’ market access and HEOR experts can guide you…
Our dedicated global team works in partnership with pharmaceutical, biotech and medical devices & diagnostics clients – to generate evidence, design strategies that drive multi-stakeholder value, and facilitate patient access to critical healthcare interventions.
Our Evidence, Value & Access Proposition 
Solutions Across the Product Lifecycle
EVIDENCE:
Evidence generation strategy • Evidence synthesis • Prospective & retrospective real world data collection • Publication for scientific purpose
VALUE:
Demand assessment & forecasting • Pricing strategy & revenue optimisation • Health economic evaluation, HTA dossiers & field tools • Value communication & advocacy
ACCESS:
Access & HTA / reimbursement strategy • Landscaping, stakeholder mapping and engagement • Innovative contracting & value-based solutions • Negotiation strategy & objection handling
Why Ipsos for Market Access & HEOR?
- Expertise: A globally-led EVA practice, delivered by local market experts
- Reach: Unparalleled access to all relevant stakeholders
- Innovation: Industry-leading innovations (often powered by Ipsos’ GenAI platform)
- Compliance: Rigorous adherence to quality & compliance standards
- Client Focus: A laser focus on our client’s unique challenges & needs
- Added Value: Ipsos’ Healthcare Centres of Expertise enriching EVA approaches
Our Recent Thought Leadership
Posters & Presentations
ISPOR 2024 Poster: AI-Powered Identification, Access & Utility Mapping of Real-World Data Sources for Alzheimer’s Disease in Europe
ISPOR 2024 Poster: AI-Powered Identification, Access & Utility Mapping of Real-World Data Sources for Alzheimer’s Disease in Asia
ISPOR 2024 Poster: Artificial Intelligence: A New Era in Payer Decision Making?
ISPOR 2024 Presentation: An Insight into Non-Interventional Studies as a Component of Submission to NICE & CAD in the Last 3 Years
ISPOR 2024 Presentation: Current & Future Use of RWE in HTA Decision-making: A Global Payer View
EPA 2023 Presentation: 30 Future Challenges In Evidence, Pricing & Access & How To Overcome Them
EPA 2023 Presentation: The Integration of Data Collected by Wearables in the Payer Evidence Strategy
Articles, Papers & Reports
Journal Article: The Economic Burden of Obesity in 4 South-Eastern European Countries Associated With Obesity-Related Co-Morbidities
Paper: An Experts' Consensus on the Role of Psyllium Fibre Dietary Supplement in Early Intervention of Chronic Diseases
Journal Article: Physician Perceptions of the Clinical, Economic & Humanistic Burden of Disease and Unmet Needs in Myelofibrosis (Indonesia)
Paper: An Experts’ Consensus on the Impact and Management of Sleep Deprivation
Journal Article: What Will the Legislative Proposal for Joint Work on European HTA Approach Mean for Access in Europe?
Paper: Leveraging Real-World Evidence to Drive Pricing & Access
Paper: Modernization of Thailand Health Technology Assessment
Report: Flu in the Philippines: Insights into Perception and Action on Vaccination
Paper: Rethinking Alzheimer’s: From Silent Epidemic to Measurable Value
Webinars
Webinar: The Power of Holistic Insights in Oncology
Webinar: The Role of the Patient Voice in Access to Treatments
Talk to us about your Market Access & HEOR questions today.